SCHEMBL30865437

SCHEMBL30865437

O=C(N1CC2(CC(n3cnc(C4CC4)n3)C2)C1)N1CC2(CN(Cc3cn[nH]c3C(F)(F)F)C2)C1

nearest known ligand 0.80

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 6/20 0.80
▸ CNR2 P34972 8/20 0.32
▸ CNR1 P21554 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30865347 0.89 MGLL (1.00) MGLL
SCHEMBL30865288 0.89 MGLL (0.63) MGLLCNR2CNR1
SCHEMBL30865267 0.86 MGLL (0.60) MGLLCNR2CNR1
SCHEMBL30865274 0.84 MGLL (0.62) MGLL
SCHEMBL30865375 0.83 MGLL (0.60) MGLL
SCHEMBL30865410 0.82 MGLL (0.57) MGLL
SCHEMBL30865270 0.82 MGLL (0.59) MGLL
SCHEMBL30865185 0.81 MGLL (0.58) MGLL
SCHEMBL30865142 0.81 MGLL (0.56) MGLL
SCHEMBL30720270 0.81 MGLL (0.58) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4608823-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. Hoffmann-La Roche AG (CH) 2025-09-03 — — EP claimed
WO-2024088922-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. HOFFMANN-LA ROCHE AG (CH) 2024-05-02 — — WO claimed
EP-4608823-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. Hoffmann-La Roche AG (CH) 2025-09-03 — — EP disclosed
WO-2024088922-A1 HETEROCYCLIC COMPOUNDS AS INHIBITORS OF MONOACYLGLYCEROL LIPASE (MAGL) F. HOFFMANN-LA ROCHE AG (CH) 2024-05-02 — — WO disclosed
Send feedback